Online Prehabilitation for Patients Awaiting Liver Transplantation
OPAL
OPAL: Online Prehabilitation for Patients Awaiting Liver Transplantation - a Multicenter Randomized Controlled Trial to Reduce Physical Frailty and Improve Health Outcomes
1 other identifier
interventional
177
1 country
6
Brief Summary
Physical frailty is common in patients awaiting liver transplantation and has been associated with poor health outcomes. There is promising data from small studies showing that behavioural, nutrition, exercise therapy (prehabilitation) improves physical function in patients while they are waiting for a liver transplant. The proposed trial will assess if a 12-week online prehabilitation program improves physical function in patients listed for liver transplantation. Over 4 years, 177 patients will be recruited from 6 transplant centres across Canada and will be randomized to receive either the online prehabilitation program or usual care. The primary outcome of physical function will be evaluated using the FTSST at baseline and 12 weeks (or last timepoint before transplant) assessed virtually or in-person. Secondary outcomes include liver specific physical frailty, aerobic fitness, health-related quality of life (QoL), participant experience and acceptability. Exploratory outcomes include other virtual and in-person physical function measures, covert hepatic encephalopathy (CHE), sarcopenia, malnutrition, adherence, behaviour factors, clinical and post-transplant outcomes. Results will be compared between the intervention and usual care groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedStudy Start
First participant enrolled
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
April 8, 2026
April 1, 2026
3.1 years
May 15, 2023
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in time to do 5-sit-to-stands from baseline
A time to complete 5 chair stands of \>15 seconds predicts morbidity and mortality in patients with cirrhosis. This test shows promise as a frailty measure that could be evaluated over a virtual platform
Week 0
Change in time to do 5-sit-to-stands from baseline
A time to complete 5 chair stands of \>15 seconds predicts morbidity and mortality in patients with cirrhosis. This test shows promise as a frailty measure that could be evaluated over a virtual platform
Week 12
Secondary Outcomes (9)
Change in liver frailty index from baseline
Week 0
Change in liver frailty index from baseline
Week 12
Changes in virtual physical function testing over time (2-min step test)
Week 0
Changes in virtual physical function testing over time (2-min step test)
Week 12
Change in health-related quality of life from baseline (CLDQ)
Week 0
- +4 more secondary outcomes
Other Outcomes (47)
Change in time to do 5-sit-to-stands from baseline
Week 8
Change in sarcopenia from baseline
Week 0
Change in sarcopenia from baseline
Week 12
- +44 more other outcomes
Study Arms (2)
Prehabilitation Group
EXPERIMENTALThe prehabilitation group will be provided with access to the online digital web platform which contains the weekly acceptance and commitment therapy based education videos, nutrition intervention, and exercise intervention.
Usual Care
NO INTERVENTIONThis group will receive standard care for LT candidates with cirrhosis and will be provided with standard online exercise, nutrition, and behavioural resources. Control participants will not receive access to the online digital platform.
Interventions
12-weeks of online prehabilitation programming including: 1.12 weeks of nutrition programming focused on achieving a guideline- based protein intake of 1.2-1.5 g/kg/day. Participants will participate in a dietitian assessment and 0-2 dietitian follow-ups stratified by risk and 5 virtual group nutrition classes. Participants will be provided with a whey protein powder supplement - dosing stratified by risk. 2.10 weeks of exercise programming focused on completion of 3 full- body resistance/aerobic exercise sessions weekly (1 or 2 virtual group classes as per patient preference + 1 or 2 pre-recorded home exercise videos). 3.12 weeks of acceptance and commitment therapy based educational videos and online activities focused on reducing stress and anxiety and improving motivation and adherence.
Eligibility Criteria
You may qualify if:
- ≥18 years old with cirrhosis (confirmed with transient elastography by FibroScan, histology, or imaging-based assessment with compatible clinical picture), referred for transplant and are assessed to have a high likelihood of being listed according to a preliminary review by hepatologist or are already listed for LT, are pre-frail or frail on the liver frailty index (LFI) or (added August 30, 2024) pre-frail or frail on the TeLeFI (prefrail LFI 3.2-4.3 and frail LFI ≥4.4), have English or French language proficiency, and own an internet-connected device.
You may not qualify if:
- Listed for living related donor transplantation with expected time on the wait list \<12 weeks, or model for end-stage liver disease (MELD-Na) Score \>26 (Justification: time to transplant is very short)
- Robust status on frailty testing (LFI 0-3.1) (Justification: unlikely to see benefit)
- Unable to provide informed consent
- Presence of a clinical condition that makes the intervention unsafe or infeasible (e.g. unable to follow instruction) or unsafe environment for virtual participation
- Life expectancy less than 6 months, compassionate care (clinician judgment) (Justification: unlikely to see benefit)
- Recent variceal bleed or history of varices not on adequate prophylaxis (Justification: acute exercise increases portal pressure
- Transplant indication is cholangiocarcinoma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Foothills Medical Centre
Calgary, Alberta, T2N 2T9, Canada
Kaye Edmonton Clinic
Edmonton, Alberta, T6G1Z1, Canada
Gordon and Leslie Diamond Health Care Centre
Vancouver, British Columbia, V5Z 1M9, Canada
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
Toronto General Hospital - Ajmera Transplant Centre
Toronto, Ontario, M5G 0A3, Canada
McGill University Health Centre
Montreal, Quebec, H4A3J1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Puneeta Tandon
University of Alberta
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2023
First Posted
June 12, 2023
Study Start
July 12, 2023
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share